The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...
3don MSN
Georgia bill would allow pharmacists to prescribe PrEP in effort to expand HIV prevention access
A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that ...
Hosted on MSN
CDC cuts hit HIV prevention program, jeopardizing decades of progress on reducing infant transmission rates
Public health, explained: Sign up to receive Healthbeat’s free Atlanta newsletter here. The sharp job cuts at the Centers for Disease Control and Prevention include a successful program reducing HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results